BCL2 and acute myeloid leukemia: These observations suggested that Notch inhibition could revert hBM-MSCs-mediated AML chemoresistance by modulating the balance between pro-apoptotic and anti-apoptotic of the Bcl-2 family protein and the level of full-length caspase3.